New Harbor Financial Group, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
New Harbor Financial Group, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,244
-53.9%
10,4100.0%0.00%
-50.0%
Q2 2023$13,533
-26.1%
10,4100.0%0.00%
-33.3%
Q1 2023$18,322
-43.9%
10,4100.0%0.01%
-57.1%
Q4 2022$32,687
-35.9%
10,4100.0%0.01%
-46.2%
Q3 2022$51,00010,4100.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders